Viewing Study NCT06868433


Ignite Creation Date: 2025-12-25 @ 2:50 AM
Ignite Modification Date: 2025-12-31 @ 7:00 PM
Study NCT ID: NCT06868433
Status: RECRUITING
Last Update Posted: 2025-08-19
First Post: 2025-03-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer
Sponsor: Emory University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module